Cardinal Health (CAH) Gets a Sell Rating from Morgan Stanley

Morgan Stanley analyst Ricky Goldwasser maintained a Sell rating on Cardinal Health (CAH) today and set a price target of $50. The company’s shares closed on Friday at $54.83.

According to, Goldwasser is a 3-star analyst with an average return of 3.0% and a 56.2% success rate. Goldwasser covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Walgreens Boots Alliance, and Quest Diagnostics Inc.

Cardinal Health has an analyst consensus of Hold, with a price target consensus of $55.

See today’s analyst top recommended stocks >>

The company has a one-year high of $75.75 and a one-year low of $48.14. Currently, Cardinal Health has an average volume of 3.6M.

Based on the recent corporate insider activity of 42 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cardinal Health, Inc. engages in the provision of pharmaceutical and medical products. It operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States.